Lantern Pharma Inc (LTRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 22,216 | 17,878 | 14,433 | 12,592 | 5,908 |
| Operating Income | -22,216 | -17,878 | -14,433 | -12,592 | -5,908 |
| Other Income | 1,435 | 1,916 | 173 | 229 | 0 |
| Pre-tax Income | -20,781 | -15,962 | -14,260 | -12,363 | -5,908 |
| Net Income Continuous | -20,781 | -15,962 | -14,260 | -12,363 | -5,908 |
| Net Income | $-20,781 | $-15,962 | $-14,260 | $-12,363 | $-5,908 |
| EPS Basic Total Ops | -1.93 | -1.47 | -1.31 | -1.13 | -1.37 |
| EPS Basic Continuous Ops | -1.93 | -1.47 | -1.31 | -1.13 | -1.37 |
| EPS Diluted Total Ops | -1.93 | -1.47 | -1.31 | -1.13 | -1.37 |
| EPS Diluted Continuous Ops | -1.93 | -1.47 | -1.31 | -1.13 | -1.37 |
| EPS Diluted Before Non-Recurring Items | -1.93 | -1.47 | -1.31 | -1.13 | -1.37 |
| EBITDA(a) | $-22,438 | $-18,036 | $-14,341 | $-12,444 | $-5,905 |